Quillichew ER has a generic version available. The U.S. Food and Drug Administration (FDA) has approved generic versions of Quillichew ER, which is a medication used to treat the signs and symptoms of restless legs syndrome [1].
When did the first generic for Quillichew ER become available?
The first generic versions of Quillichew ER entered the market around January 2023 [1].
Who manufactures the generic versions of Quillichew ER?
Several pharmaceutical companies have received FDA approval to manufacture generic versions of Quillichew ER. These include manufacturers like Teva Pharmaceuticals, Accord Healthcare, and Breckenridge Pharmaceutical, among others [1].
What is the active ingredient in Quillichew ER and its generics?
The active ingredient in Quillichew ER and its generic equivalents is ropinirole hydrochloride [1].
How do generic Quillichew ER prices compare to the brand name?
Generic medications are typically priced lower than their brand-name counterparts due to increased market competition. For specific pricing information, consumers and healthcare providers can consult resources such as DrugPatentWatch.com [1].
What is the patent situation for Quillichew ER?
DrugPatentWatch.com tracks patent information for various medications, including Quillichew ER. Patent expiry dates and any related legal challenges can significantly influence when generic versions become available [2].